The prevalence of obstructive sleep apnea (OSA) is significantly higher in individuals with obesity, says Dr
Probiotics and the microbiomehow can we help patients make sense of probiotics
#GLP1 receptor agonists are supported by preclinical and observational evidence for reducing addictive behaviors, particularly alcohol and nicotine use
The model was refined against one half map, and FSC curves were calculated between this model and the final cryo-EM map (full dataset, blue) of the outcome of model refinement with a half map versus the same map (orange), and of the outcome of model refinement with a half map versus the other half map (green)
GLP-1 analogues, once viewed mainly as glucose-lowering drugs, are now redefining obesity treatment, cardiovascular risk management, chronic kidney disease care, MASH/NASH research, and long-term metabolic disease prevention